<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 15:45:42[mciao0826] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<chemical  confidence="0.9511911446218017" wordnetid="114806838">
<antioxidant  confidence="0.9511911446218017" wordnetid="114724645">
<header>
<title>Tocopherol</title>
<id>54105</id>
<revision>
<id>237993722</id>
<timestamp>2008-09-12T19:25:34Z</timestamp>
<contributor>
<username>Rearden9</username>
<id>393182</id>
</contributor>
</revision>
<categories>
<category>Food antioxidants</category>
<category>Dietary antioxidants</category>
<category>Cosmetic chemicals</category>
<category>Vitamins</category>
<category>Pages with DOIs broken since 2008</category>
<category>Wikipedia articles needing clarification</category>
</categories>
</header>
<bdy>

<table style="float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" width="250px" class="toccolours" border="1">
<header colspan="2" style="width: 30%; background: #F8EABA; text-align: center;">
α-Tocopherol<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref></header>
<row>
<col colspan="2" align="center" bgcolor="#ffffff">
 <image width="300px" src="Tocopherol,_alpha-.svg">
</image>
</col>
</row>


<row>
<col>
 <link xlink:type="simple" xlink:href="../503/3141503.xml">
IUPAC name</link></col>
<col>
 (<it>2R</it>)-2,5,7,8-Tetramethyl-2-[(''4R,8R'')-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol</col>
</row>
<row>
<header>
style="background: #F8EABA; text-align: center;" colspan="2"</header>
<header>
style="background: #F8EABA; text-align: center;" colspan="2"</header>
<col colspan="2" style="width: 30%; background: #F8EABA; text-align: center;">
 Except where noted otherwise, data are given for materials in their <link xlink:type="simple" xlink:href="../224/240224.xml">
standard state(at 25&nbsp;°C, 100&nbsp;kPa)</link></col>
</row>
</table>

<b>Tocopherol</b>, a class of chemical compounds of which many have <link xlink:type="simple" xlink:href="../104/54104.xml">
vitamin E</link> activity, describes a series of <link xlink:type="simple" xlink:href="../203/22203.xml">
organic compounds</link> consisting of various methylated phenols. Because the vitamin activity was first identified in 1936 from a dietary fertility factor in rats, it was given the name "tocopherol" from the Greek words “τοκος” [birth], and “φορειν”, [to bear or carry] meaning in sum "to carry a pregnancy," with the ending "-ol" signifying its status as a chemical alcohol.<p>

Tocotrienols, which are related compounds, may also have vitamin E activity. All of these various derivatives with vitamin activity may correctly be referred to as "vitamin E." Tocopherols and tocotrienols are fat-soluble <link xlink:type="simple" xlink:href="../277/3277.xml">
antioxidant</link>s. </p>
<p>

The compound <b>α-tocopherol</b>, a common form of tocopherol added to food products, is denoted by the <link xlink:type="simple" xlink:href="../221/43221.xml">
E number</link> <b>E307</b>.</p>

<sec>
<st>
Forms</st>

<p>

Vitamin E exists in eight different forms, four tocopherols and four <link xlink:type="simple" xlink:href="../306/2891306.xml">
tocotrienol</link>s. All feature a chromanol ring, with a <link xlink:type="simple" xlink:href="../386/14386.xml">
hydroxyl</link> group that can donate a <link xlink:type="simple" xlink:href="../255/13255.xml">
hydrogen</link> atom to <link xlink:type="simple" xlink:href="../313/66313.xml">
reduce</link> <link xlink:type="simple" xlink:href="../028/235028.xml">
free radical</link>s and a <link xlink:type="simple" xlink:href="../136/14136.xml">
hydrophobic</link> <link xlink:type="simple" xlink:href="../896/1152896.xml">
side chain</link> which allows for penetration into <link xlink:type="simple" xlink:href="../817/4817.xml">
biological membrane</link>s. Both the tocopherols and tocotrienols occur in alpha, beta, gamma and delta forms, determined by the number of <link xlink:type="simple" xlink:href="../839/19839.xml">
methyl</link> groups on the chromanol ring. Each form has slightly different <link xlink:type="simple" xlink:href="../629/4387629.xml">
biological activity</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref>
<image location="center" width="450px" src="VitE.png">
</image>
</p>
<p>

As a <link xlink:type="simple" xlink:href="../815/11815.xml">
food additive</link>, tocopherol is labeled with these <link xlink:type="simple" xlink:href="../221/43221.xml">
E number</link>s: <b>E307</b> (α-tocopherol), <b>E308</b> (γ-tocopherol), and <b>E309</b> (δ-tocopherol). </p>

<ss1>
<st>
Alpha-tocopherol</st>

<p>

Alpha-tocopherol is the form of vitamin E that is preferentially absorbed and accumulated in humans.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref> The measurement of "vitamin E" activity in <link xlink:type="simple" xlink:href="../802/865802.xml">
international units</link> (IU) was based on fertility enhancement by the prevention of spontaneous abortions in pregnant rats relative to alpha-tocopherol. </p>
<p>

There are three <link xlink:type="simple" xlink:href="../476/522476.xml">
stereocenter</link>s in alpha-tocopherol, so this is a <link xlink:type="simple" xlink:href="../166/1170166.xml">
chiral</link> molecule. The eight <link xlink:type="simple" xlink:href="../970/27970.xml">
stereoisomers</link> of alpha-tocopherol differ in the arrangement of groups around these stereocenters. In the image of <it>RRR</it>-alpha-tocopherol below, all three stereocenters are in the <it>R</it> form. However, if the middle of the three stereocenters were changed (so the hydrogen was now pointing down and the <link xlink:type="simple" xlink:href="../839/19839.xml">
methyl group</link> pointing up), this would become the structure of <it>RSR</it>-alpha-tocopherol. <it>RSR</it>-alpha-tocopherol and <it>RRR</it>-alpha-tocopherol are mirror-images of each other. These stereoisomers can also be named in an alternative older nomenclature, where the stereocenters are either in the <it>d</it> or <it>l</it> form.</p>
<p>

<image location="right" width="250px" src="RRR_alpha-tocopherol.png" type="thumb">
<caption>

<it>RRR</it> <link xlink:type="simple" xlink:href="../970/27970.xml">
stereoisomer</link> of alpha-tocopherol, bonds around the <link xlink:type="simple" xlink:href="../476/522476.xml">
stereocenter</link>s are shown as dashed lines (pointing down) or wedges (pointing up).
</caption>
</image>
</p>
<p>

1 IU of tocopherol is defined as ⅔ milligrams of <it>RRR</it>-alpha-tocopherol (formerly named d-alpha-tocopherol or sometimes ddd-alpha-tocopherol). 1 IU is also defined as 1 milligram of an equal mix of the eight stereoisomers, which is a <link xlink:type="simple" xlink:href="../089/75089.xml">
racemic mixture</link> called <it>all-rac</it>-alpha-tocopheryl acetate. This mix of stereoisomers is often called dl-alpha-tocopheryl acetate, even though it is more precisely dl,dl,dl-alpha-tocopheryl acetate). However, 1 IU of this racemic mixture is not now considered equivalent to 1 IU of natural (RRR) α-tocopherol, and the <institution wordnetid="108053576" confidence="0.8">
<academy wordnetid="108279298" confidence="0.8">
<link xlink:type="simple" xlink:href="../259/431259.xml">
Institute of Medicine</link></academy>
</institution>
 and the <link xlink:type="simple" xlink:href="../896/70896.xml">
USDA</link> now convert IU's of the racemic mixture to milligrams of equivalent RRR using 1 IU racemic mixture = 0.45 "milligrams α-tocopherol".<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref></p>

</ss1>
<ss1>
<st>
Other R, R, R tocopherol</st>

<p>

The other R, R, R tocopherol vitamins are slowly being recognized as research begins to elucidate their additional roles in the human body. Many naturopathic and <link xlink:type="simple" xlink:href="../995/327995.xml">
orthomolecular medicine</link> advocates suggest that vitamin E supplements contain at least 20% by weight of the other natural vitamin E isomers.</p>

</ss1>
<ss1>
<st>
Tocotrienols</st>

<p>

<link xlink:type="simple" xlink:href="../306/2891306.xml">
Tocotrienol</link>s, with four d- isomers, also belong to the vitamin E family. The four tocotrienols have structures corresponding to the four tocopherols, except with an unsaturated bond in each of the three isoprene units that form the hydrocarbon tail. Tocopherols have a saturated phytyl tail.</p>

</ss1>
</sec>
<sec>
<st>
History</st>

<p>

During feeding experiments with rats <physical_entity wordnetid="100001930" confidence="0.8">
<expert wordnetid="109617867" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<anatomist wordnetid="109792237" confidence="0.8">
<biologist wordnetid="109855630" confidence="0.8">
<geneticist wordnetid="110126424" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<scientist wordnetid="110560637" confidence="0.8">
<link xlink:type="simple" xlink:href="../501/780501.xml">
Herbert McLean Evans</link></scientist>
</causal_agent>
</geneticist>
</biologist>
</anatomist>
</person>
</expert>
</physical_entity>
 concluded in 1922 that besides vitamins B and C, an unknown vitamin existed.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref> Although every other nutrition was present, the rats were not fertile. This condition could be changed by additional feeding with wheat germ. It took several years until 1936 when the substance was isolated from wheat germ and the formula C29H50O2 was determined. Evans also found that the compound reacted like an <link xlink:type="simple" xlink:href="../014/1014.xml">
alcohol</link> and concluded that one of the oxygen atoms was part of an OH (hydroxyl) group. As noted in the introduction, the vitamin was given its name by Evans from Greek words meaning "to bear young" with the addition of the -ol as an alcohol.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref>
The structure was determined shortly thereafter in 1938.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref></p>

</sec>
<sec>
<st>
Recommended amounts</st>

<p>

The U.S. <link xlink:type="simple" xlink:href="../054/396054.xml">
Dietary Reference Intake</link> (DRI) Recommended Daily Amount (RDA) for a 25-year old male for Vitamin E is 15 mg/day. The DRI for vitamin E is based on the alpha-tocopherol form because it is the most active form as originally tested. Results of two national surveys, the National Health and Nutrition Examination Survey (NHANES III 1988-91) and the Continuing Survey of Food Intakes of Individuals (1994 CSFII) indicated that the dietary intakes of most Americans do not provide the recommended amounts of vitamin E. However, a 2000 <institution wordnetid="108053576" confidence="0.8">
<academy wordnetid="108279298" confidence="0.8">
<link xlink:type="simple" xlink:href="../259/431259.xml">
Institute of Medicine</link></academy>
</institution>
 (IOM) report on vitamin E states that intake estimates of vitamin E may be low because energy and fat intake is often underreported in national surveys and because the kind and amount of fat added during cooking is often not known. The IOM states that most North American adults get enough vitamin E from their normal diets to meet current recommendations. However, they do caution individuals who consume low fat diets because vegetable oils are such a good dietary source of vitamin E. "Low-fat diets can substantially decrease vitamin E intakes if food choices are not carefully made to enhance alpha-tocopherol intakes". Vitamin E supplements are absorbed best when taken with meals.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref></p>
<p>

Because vitamin E can act as an <link xlink:type="simple" xlink:href="../212/178212.xml">
anticoagulant</link> and may increase the risk of bleeding problems, many agencies have set an upper tolerable intake level (UL) for vitamin E at 1,000 mg (1,500 IU) per day.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref></p>

</sec>
<sec>
<st>
Sources</st>

<p>

In foods, the most abundant sources of vitamin E are <link xlink:type="simple" xlink:href="../331/192331.xml">
vegetable oil</link>s such as <link xlink:type="simple" xlink:href="../561/57561.xml">
palm oil</link>, <link xlink:type="simple" xlink:href="../622/57622.xml">
sunflower</link>, <link xlink:type="simple" xlink:href="../397/20397.xml">
corn</link>, <link xlink:type="simple" xlink:href="../784/62784.xml">
soybean</link>, and <link xlink:type="simple" xlink:href="../478/22478.xml">
olive oil</link>. <fruit wordnetid="113134947" confidence="0.8">
<natural_object wordnetid="100019128" confidence="0.8">
<reproductive_structure wordnetid="111675842" confidence="0.8">
<seed wordnetid="113135832" confidence="0.8">
<plant_organ wordnetid="113087625" confidence="0.8">
<plant_part wordnetid="113086908" confidence="0.8">
<substance wordnetid="100020090" confidence="0.8">
<bite wordnetid="107577374" confidence="0.8">
<edible_nut wordnetid="107737081" confidence="0.8">
<food wordnetid="100021265" confidence="0.8">
<nut wordnetid="113136556" confidence="0.8">
<nutriment wordnetid="107570720" confidence="0.8">
<meal wordnetid="107573696" confidence="0.8">
<link xlink:type="simple" xlink:href="../647/251647.xml">
Nuts</link></meal>
</nutriment>
</nut>
</food>
</edible_nut>
</bite>
</substance>
</plant_part>
</plant_organ>
</seed>
</reproductive_structure>
</natural_object>
</fruit>
, <link xlink:type="simple" xlink:href="../706/58706.xml">
sunflower seeds</link>, <link xlink:type="simple" xlink:href="../058/1005058.xml">
seabuckthorn</link> berries, kiwi fruit, and <link xlink:type="simple" xlink:href="../652/1437652.xml">
wheat germ</link> are also good sources. Other sources of vitamin E are <link xlink:type="simple" xlink:href="../597/2052597.xml">
whole grains</link>, <link xlink:type="simple" xlink:href="../587/4699587.xml">
fish</link>, <link xlink:type="simple" xlink:href="../786/289786.xml">
peanut butter</link>, goats milk, and <link xlink:type="simple" xlink:href="../759/1594759.xml">
green leafy vegetables</link>. Fortified <link xlink:type="simple" xlink:href="../776/82776.xml">
breakfast cereal</link>s are also an important source of vitamin E in the United States. Although originally extracted from wheat germ oil, most natural vitamin E supplements are now derived from vegetable oils, usually soybean oil.</p>
<p>

The content of Vitamin E for rich sources follows:<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref></p>
<p>

<list>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../464/5982464.xml">
Wheat germ oil</link> (215.4 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../902/2921902.xml">
Sunflower oil</link> (55.8 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../064/1064.xml">
Almond oil</link> (39.2 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../546/484546.xml">
Hazelnut</link> (26.0 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../431/1208431.xml">
Walnut oil</link> (20.0 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../910/1195910.xml">
Peanut oil</link> (17.2 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../478/22478.xml">
Olive oil</link> (12.0 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../602/55602.xml">
Peanut</link> (9.0 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../439/99439.xml">
Pollard</link> (2.4 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../397/20397.xml">
Corn</link> (2.0 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../319/46319.xml">
Asparagus</link> (1.5 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../573/46573.xml">
Oats</link> (1.5 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../733/67733.xml">
Chestnut</link> (1.2 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../346/51346.xml">
Coconut</link> (1.0 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../234/9940234.xml">
Tomatoes</link> (0.9 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../739/5985739.xml">
Carrots</link> (0.6 mg/100 g)</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../714/19714.xml">
Goat's milk</link> (0.1 mg/100ml)</entry>
</list>
</p>


</sec>
<sec>
<st>
Deficiency</st>

<p>

Vitamin E deficiency causes neurological problems due to poor nerve conduction. These include neuromuscular problems such as <link xlink:type="simple" xlink:href="../494/2304494.xml">
spinocerebellar ataxia</link> and <link xlink:type="simple" xlink:href="../683/1531683.xml">
myopathies</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref> Deficiency can also cause <link xlink:type="simple" xlink:href="../537/83537.xml">
anemia</link>, due to oxidative damage to red blood cells.</p>
<p>

Vitamin E deficiency is very rare in humans and is almost never caused by a poor diet.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref> Instead, there are three specific situations when a vitamin E deficiency is likely to occur. It is seen in persons who cannot absorb dietary fat, has been found in premature, very low birth weight infants (birth weights less than 1500 grams, or 3.5 pounds), and is seen in individuals with rare disorders of fat metabolism.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2212%22])">12</ref></p>
<p>

Individuals who cannot absorb fat may require a vitamin E supplement because some dietary fat is needed for the absorption of vitamin E from the gastrointestinal tract. Anyone diagnosed with <link xlink:type="simple" xlink:href="../601/50601.xml">
cystic fibrosis</link>, individuals who have had part or all of their stomach removed, and individuals with malabsorptive problems such as <link xlink:type="simple" xlink:href="../522/63522.xml">
Crohn's disease</link>, <link xlink:type="simple" xlink:href="../271/865271.xml">
liver disease</link> or <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../371/3952371.xml">
pancreatic insufficiency</link></disease>
 may not absorb fat and should discuss the need for supplemental vitamin E with their physician (3). People who cannot absorb fat often pass greasy stools or have chronic diarrhea and bloating.</p>
<p>

Very low birth weight infants may be deficient in vitamin E. A <link xlink:type="simple" xlink:href="../489/1466489.xml">
neonatologist</link>, a <link xlink:type="simple" xlink:href="../593/23593.xml">
pediatrician</link> specializing in the care of newborns, typically evaluates the nutritional needs of premature infants.</p>
<p>

<link xlink:type="simple" xlink:href="../451/68451.xml">
Abetalipoproteinemia</link> is a rare inherited disorder of fat metabolism that results in poor absorption of dietary fat and vitamin E.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2213%22])">13</ref> The vitamin E deficiency associated with this disease causes problems such as poor transmission of nerve impulses, muscle weakness, and degeneration of the retina that can cause blindness. Individuals with abetalipoproteinemia may be prescribed special vitamin E supplements by a physician to treat this disorder. In addition, there is a rare genetic condition termed isolated vitamin E deficiency or ataxia with isolated with vitamin E deficiency, caused by mutations in the gene for the tocopherol transfer protein.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2214%22])">14</ref> These individuals have an extremely poor capacity to absorb vitamin E and develop neurological complications that are reversed by high doses of vitamin E.</p>

</sec>
<sec>
<st>
Supplements</st>

<p>

Commercial vitamin E supplements can be classified into several distinct categories:
<list>
<entry level="1" type="bullet">

 Fully synthetic vitamin E, "dl-alpha-tocopherol", the most inexpensive, most commonly sold supplement form usually as the acetate ester;</entry>
<entry level="1" type="bullet">

 Semi-synthetic "natural source" vitamin E esters, the "natural source" forms used in tablets and multiple vitamins. These are highly fractionated d-alpha tocopherol or its esters, often made by synthetic methylation of gamma and beta d,d,d tocopherol vitamers extracted from plant oils.</entry>
<entry level="1" type="bullet">

 Less fractionated "natural mixed tocopherols" and high d-gamma-tocopherol fraction supplements</entry>
</list>
</p>

<ss1>
<st>
Synthetic all-racemic</st>

<p>

Synthetic vitamin E derived from petroleum products is manufactured as all-<link xlink:type="simple" xlink:href="../089/75089.xml">
racemic</link> alpha tocopheryl acetate with a mixture of eight stereoisomers. In this mixture, one alpha-tocopherol molecule in eight molecules are in the form of <it>RRR</it>-alpha-tocopherol (12.5% of the total).<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2215%22])">15</ref></p>
<p>

The 8-isomer <it>all-rac</it> vitamin E is always marked on labels simply as <b>dl-tocopherol</b> or <b>dl-tocopheryl acetate</b>, even though it is (if fully written out) actually dl,dl,dl-tocopherol. The present largest manufacturers of this type are <link xlink:type="simple" xlink:href="../590/167590.xml">
DSM</link> and <company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../595/171595.xml">
BASF</link></company>
.</p>
<p>

(An earlier semisynthetic vitamin E actually contained 50% d,d,d-alpha tocopherol moiety and 50% l,d,d-alpha-tocopherol moiety, as synthesized by an earlier process which started with a plant sterol intermediate with the correct chirality in the tail, and thus resulted in a racemic mixture at only one chiral center. This form, known as 2-ambo tocopherol, is no longer made.)</p>
<p>

Natural alpha-tocopherol is the RRR-alpha (or ddd-alpha) form. The synthetic dl,dl,dl-alpha ("dl-alpha") form is not as active as the natural ddd-alpha ("d-alpha") tocopherol form. This is mainly due to reduced vitamin activity of the 4 possible stereoisomers which are represented by the <it>l</it> or <it>S</it> enantiomer at the first stereocenter (an S or l configuration between the chromanol ring and the tail, i.e., the SRR, SRS, SSR, and SSS stereoisomers).<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2216%22])">16</ref> Unnatural 2R stereoisomers with natural R configuration at this stereocenter, but S at the other centers in the tail (RSR, RRS), appear to retain substantial RRR vitamin activity because they are recognized by the alpha-tocopherol transport protein, and thus maintained in the plasma, where the other four stereoisomers are not. Thus, the synthetic all-rac-α-tocopherol probably has only about half the vitamin activity of RRR-alpha-tocopherol in humans, even though the ratio of activities of the 8 stereoisomer racemic mixture to the natural vitamin is 1 to 1.36 in the rat pregnancy model. <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2217%22])">17</ref></p>
<p>

Although it is clear that mixtures of stereoisomers are not as active as the natural <it>RRR</it>-alpha-tocopherol form, in the ratios discussed above, specific information on any side effects of the seven synthetic vitamin E stereoisomers is not readily available.  Naturopathic and orthomolecular medicine advocates have held  that none of the other stereoisomers of vitamin E have merit for cancer, circulatory and heart diseases, but hold this opinion without being able to point to definitive studies of the matter.</p>

</ss1>
<ss1>
<st>
Esters</st>
<p>

Manufacturers also commonly convert the phenol form of the vitamins (with a free <link xlink:type="simple" xlink:href="../386/14386.xml">
hydroxyl</link> group) to <link xlink:type="simple" xlink:href="../675/9675.xml">
ester</link>s, using acetic or succinic acid. These tocopheryl esters are more stable and are easy to use in vitamin supplements. Alpha tocopheryl esters are de-esterified in the gut and then absorbed as the free tocopherol.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2218%22])">18</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2219%22])">19</ref> 
<image location="left" width="200px" src="Tocopherylacetat.svg" type="thumb">
<caption>

Alpha tocopheryl acetate, an <link xlink:type="simple" xlink:href="../637/194637.xml">
acetate</link> <link xlink:type="simple" xlink:href="../675/9675.xml">
ester</link> of alpha-tocopherol.
</caption>
</image>

An initial study in humans saw large variability between different people's absorption of all these forms of vitamin E, with no statistically-significant differences seen between tocopheryl esters and the free tocopherol.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2220%22])">20</ref> Later studies saw no difference between the rate of absorption of these forms of vitamin E and found that tocopheryl esters and free tocopherol had the same <link xlink:type="simple" xlink:href="../021/769021.xml">
bioavailability</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2221%22])">21</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2222%22])">22</ref> The <link xlink:type="simple" xlink:href="../489/3761489.xml">
esterase</link> activity responsible for releasing the free tocopherol may be reduced in children with <link xlink:type="simple" xlink:href="../601/50601.xml">
cystic fibrosis</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2223%22])">23</ref></p>
<p>

Tocopheryl nicotinate and tocopheryl linolate esters are used in cosmetics and some pharmaceuticals.</p>

</ss1>
<ss1>
<st>
Mixed tocopherols</st>

<p>

"Mixed tocopherols" in the US contain at least 20% w/w other natural R, R,R- tocopherols, i.e. R, R,R-alpha-tocopherol content plus at least 25% R, R,R-beta-, R, R,R-gamma-, R, R,R-delta-tocopherols. </p>
<p>

Some brands may contain 200% w/w or more of the other tocopherols and measurable tocotrienols. Some mixed tocopherols with higher gamma-tocopherol content are marketed as "High Gamma-Tocopherol". The label should report each component in milligrams, except R, R,R-alpha-tocopherol may still be reported in IU. Mixed tocopherols can also be found in other nutritional supplements.</p>

</ss1>
</sec>
<sec>
<st>
Other uses</st>

<p>

Conventional medical studies on vitamin E, as of 2006 and as below, use either a synthetic all-racemic ("d, l-") alpha tocopheryl ester (acetate or succinate) or a semi-synthetic d-alpha tocopheryl ester (acetate or succinate). Proponents of megavitamin, orthomolecular and naturally based therapies have advocated, for the last two thirds of a century, and have used the <it>natural tocopherols</it>, often mixed tocopher<it>ol</it>s with an additional 25% - 200% w/w d-beta-, d-gamma-,Jiang Q et al.<weblink xlink:type="simple" xlink:href="http://www.ajcn.org/cgi/content/full/74/6/714">
"Gamma tocopherol, the major form of vitamin E in the US diet, deserves more attention"</weblink> <it>Am J Clin Nutr</it> 2001; 74: 714-22.JM Gaziano, <weblink xlink:type="simple" xlink:href="http://www.annalsnyas.org/cgi/content/abstract/1031/1/280">
Vitamin E and Cardiovascular Disease: Observational Studies</weblink>, Ann. N.Y. Acad. Sci. 1031: 280–291 (2004) " and d-delta-tocopherol. Based on various clinical, experimental, patent, and individual data, natural health proponents have long held<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2224%22])">24</ref> in combination with other antioxidants such as selenium, coQ10, vitamin C, vitamin K2, mixed carotenoids, and lipoic acid, provide unique biochemical benefits.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2225%22])">25</ref>  The methodology, interpretation and reporting of conventional vitamin E studies have even become contentious within conventional medicine circles.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2226%22])">26</ref></p>

<ss1>
<st>
Controversy</st>
<p>

"Megadoses" of Vitamin E are not recommended by many government agencies, due to a possible increased risk of bleeding. A 2005 meta-analysis by Miller found that high-dosage vitamin E supplements may increase all-cause mortality.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2227%22])">27</ref> "High dose" vitamin E esters (&amp;gt;400 units/day) were also associated with an increased risk in all-cause mortality of 39 per 10,000 persons, and a statistically significant relation existed between dose and mortality, with increased risk at doses exceeding 150 units per day. These trials included synthetic beta-carotene and other confounders.</p>
<p>

The Miller study was criticised in the Journal of the American Nutraceutical Association.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2225%22])">25</ref> <link xlink:type="simple" xlink:href="../866/1042866.xml">
Acute toxicity</link> seems to be low with one author concluding that "toxicity symptoms have not been reported even at intakes of 800 IU per kilogram of body weight daily for 5 months" according to the Food and Nutrition Board (Rosenberg, et al), an amount that corresponds to 60,000 IU per day for a 75 kg adult. </p>
<p>

A review of a number of randomized controlled trials in the scientific literature by the <link xlink:type="simple" xlink:href="../721/237721.xml">
Cochrane Collaboration</link> published in <periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../941/541941.xml">
JAMA</link></periodical>
 in 2007 also found an increase in mortality, of 4% (Relative Risk 1.04, 95% confidence interval 1.01-1.07), or 400 per 10,000 persons.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2228%22])">28</ref></p>

</ss1>
<ss1>
<st>
Topical use</st>
<p>

Vitamin E is widely used in industry as an inexpensive antioxidant (namely for cosmetics and foods). Vitamin E containing products are commonly used in the belief that vitamin E is good for the skin; many cosmetics include it, often labeled as tocopherol acetate,  tocopheryl linoleate or tocopheryl nicotinate.  Individuals can still experience allergic reactions to some tocopheryl esters or develop a rash and hives that may spread over the entire body from the use of topical products with alpha tocopheryl esters.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2229%22])">29</ref></p>

</ss1>
<ss1>
<st>
Reduce scarring</st>
<p>

<link xlink:type="simple" xlink:href="../542/867542.xml">
Topical</link> use of Vitamin E is often claimed by manufacturers of skin creams and lotions to play a role in encouraging skin healing and reducing scarring after injuries such as burns on the basis of limited research,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2230%22])">30</ref> but the weak evidence of a benefit of silicon gel sheeting with or without added Vitamin E is limited by the poor quality of the research.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2231%22])">31</ref> Indeed one study found that it did not improve or worsen the cosmetic appearance in 90% of patients, with a third developing <link xlink:type="simple" xlink:href="../633/692633.xml">
contact dermatitis</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2232%22])">32</ref></p>

</ss1>
<ss1>
<st>
During pregnancy</st>

<p>

Recent studies into the use of both <link xlink:type="simple" xlink:href="../509/32509.xml">
vitamin C</link> and the single isomer vitamin E esters as possible help in preventing oxidative stress leading to <link xlink:type="simple" xlink:href="../967/414967.xml">
pre-eclampsia</link> has failed to show significant benefits,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2233%22])">33</ref> but did increase the rate of babies born with a <link xlink:type="simple" xlink:href="../486/1995486.xml">
low birthweight</link> in one study.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2234%22])">34</ref></p>

</ss1>
<ss1>
<st>
Heart disease</st>

<p>

Preliminary research has led to a widely held belief that vitamin E may help prevent or delay <link xlink:type="simple" xlink:href="../735/5069735.xml">
coronary heart disease</link>, but larger controlled studies have not shown any benefit. Many researchers advance the belief that oxidative modification of LDL-cholesterol (sometimes called "bad" cholesterol) promotes blockages in coronary arteries that may lead to <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link> and <link xlink:type="simple" xlink:href="../969/60969.xml">
heart attacks</link>[citation needed]. Vitamin E may help prevent or delay coronary heart disease by limiting the <link xlink:type="simple" xlink:href="../313/66313.xml">
oxidation</link> of <link xlink:type="simple" xlink:href="../521/51521.xml">
LDL-cholesterol</link>. Vitamin E also may help prevent the formation of blood clots, which could lead to a heart attack. Observational studies have associated lower rates of heart disease with higher vitamin E intake. A study of approximately 90,000 nurses suggested that the incidence of heart disease was 30% to 40% lower among nurses with the highest intake of vitamin E from diet and supplements. The range of intakes from both diet and supplements in this group was 21.6 to 1,000 IU (32 to 1,500 mg), with the median intake being 208 IU (139 mg). A 1994 review of 5,133 Finnish men and women aged 30 - 69 years suggested that increased dietary intake of vitamin E was associated with decreased mortality (death) from heart disease.</p>
<p>

But even though these observations are promising, randomized clinical trials have consistently shown lack of benefit to the role of vitamin E supplements in heart disease. The Heart Outcomes Prevention Evaluation (HOPE) Study followed almost 10,000 patients for 4.5 years who were at high risk for heart attack or stroke. In this intervention study the subjects who received 265 mg (400) IU of vitamin E daily did not experience significantly fewer cardiovascular events or hospitalizations for heart failure or chest pain when compared to those who received a sugar pill. The researchers suggested that it is unlikely that the vitamin E supplement provided any protection against cardiovascular disease in the HOPE study. This study is continuing, to determine whether a longer duration of intervention with vitamin E supplements will provide any protection against cardiovascular disease.</p>
<p>

Furthermore, meta analysis of several trials of antioxidants, including vitamin E, have not shown any benefit to vitamin E supplementation for preventing coronary heart disease.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2235%22])">35</ref>  One study suggested that Vitamin E (as alpha-tocopherol only) supplementation may increase the risk for heart failure.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2236%22])">36</ref> Supplementing alpha-tocopherol without gamma-tocopherol is known to lead to reduced serum gamma- and delta-tocopherol concentrations.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2237%22])">37</ref></p>
<p>

On September 10, 2007, the <link xlink:type="simple" xlink:href="../673/581673.xml">
American Heart Association</link> (in its <link xlink:type="simple" xlink:href="../298/41298.xml">
journal</link> <link xlink:type="simple" xlink:href="../210/382210.xml">
Circulation</link>) stated that <link xlink:type="simple" xlink:href="../183/33183.xml">
women</link> taking regular doses of vitamin E or Tocopherol were 21% less likely to suffer a <link xlink:type="simple" xlink:href="../058/183058.xml">
blood clot</link>. Dr. Robert Glynn of <university wordnetid="108286163" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../529/329529.xml">
Harvard Medical School</link></university>
 said (it was an interesting finding but not yet proven and) further <link xlink:type="simple" xlink:href="../524/25524.xml">
research</link> must confirm the link in the prevention of <link xlink:type="simple" xlink:href="../048/183048.xml">
venous thromboembolism</link>, and patients must not stop taking prescribed blood thinners.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2238%22])">38</ref></p>

</ss1>
<ss1>
<st>
Cancer</st>

<p>

<link xlink:type="simple" xlink:href="../277/3277.xml">
Antioxidants</link> such as vitamin E help protect against the damaging effects of free radicals, which may contribute to the development of chronic diseases such as cancer. Vitamin E also may block the formation of <link xlink:type="simple" xlink:href="../388/1028388.xml">
nitrosamine</link>s, which are <link xlink:type="simple" xlink:href="../445/6445.xml">
carcinogen</link>s formed in the stomach from <link xlink:type="simple" xlink:href="../307/379307.xml">
nitrite</link>s consumed in the diet. It also may protect against the development of cancers by enhancing immune function. To date, human trials and surveys that have tried to associate vitamin E with incidence of cancer remain generally inconclusive.</p>
<p>

Some evidence associates higher intake of vitamin E with a decreased incidence of <link xlink:type="simple" xlink:href="../078/88078.xml">
prostate cancer</link> (see ATBC study) and <link xlink:type="simple" xlink:href="../547/70547.xml">
breast cancer</link>. Some studies correlate additional cofactors, such as specific vitamin E isomers, e.g. gamma-tocopherol, and other nutrients, e.g. <link xlink:type="simple" xlink:href="../117/27117.xml">
selenium</link>, with dramatic risk reductions in prostate cancer.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2239%22])">39</ref>  However, an examination of the effect of dietary factors, including vitamin E, on incidence of postmenopausal breast cancer in over 18,000 women from New York State did not associate a greater vitamin E intake with a reduced risk of developing breast cancer. A study of the effect on <link xlink:type="simple" xlink:href="../450/18450.xml">
lung cancer</link> in smokers also showed no benefit.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2240%22])">40</ref></p>
<p>

A study of women in Iowa provided evidence that an increased dietary intake of vitamin E may decrease the risk of <idea wordnetid="105833840" confidence="0.8">
<concept wordnetid="105835747" confidence="0.8">
<category wordnetid="105838765" confidence="0.8">
<condition wordnetid="113920835" confidence="0.8">
<state wordnetid="100024720" confidence="0.8">
<type wordnetid="105840188" confidence="0.8">
<kind wordnetid="105839024" confidence="0.8">
<link xlink:type="simple" xlink:href="../979/206979.xml">
colon cancer</link></kind>
</type>
</state>
</condition>
</category>
</concept>
</idea>
, especially in women under 65 years of age. On the other hand, vitamin E intake was not statistically associated with risk of colon cancer in almost 2,000 adults with cancer who were compared to controls without cancer.&#91;&#93; At this time there is limited evidence to recommend vitamin E supplements for the prevention of cancer.</p>
<p>

Recent studies have found that increased intake of vitamin E, especially among smokers may be responsible for an increase in the incidence of lung cancer, with one study finding an increase in the incidence of lung cancer by 7% for each 100IU of vitamin E taken daily.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2241%22])">41</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2242%22])">42</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2243%22])">43</ref></p>

</ss1>
<ss1>
<st>
Cataracts</st>

<p>

A <link xlink:type="simple" xlink:href="../931/88931.xml">
cataract</link> is a condition of clouding of the tissue of the lens of the eye. They increase the risk of disability and blindness in aging adults. Antioxidants are being studied to determine whether they can help prevent or delay cataract growth. Observational studies have found that lens clarity, which is used to diagnose cataracts, was better in regular users of vitamin E supplements and in persons with higher blood levels of vitamin E. A controlled trial of high doses of vitamins C and E and beta carotene found no effect on the risk of developing cataracts.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2244%22])">44</ref> Similarly, a trial using vitamin E alone found that vitamin E supplementation produced no change in the risk of developing cataracts or the rate of progression of existing cataracts.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2245%22])">45</ref></p>

</ss1>
<ss1>
<st>
Age-related macular degeneration (AMD) </st>

<p>

Age-related <link xlink:type="simple" xlink:href="../033/895033.xml">
macular degeneration</link> (AMD) is the leading cause of visual impairment and blindness in the United States and the developed world among people 65 years and older. It has been shown that vitamin E alone does not attenuate the development or progression of AMD.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2246%22])">46</ref></p>
<p>

However, studies focusing on efficacy of Vitamin E combined with other antioxidants, like zinc and vitamin C, indicate a protective effect against the onset and progression of AMD<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2247%22])">47</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2248%22])">48</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2249%22])">49</ref></p>

</ss1>
<ss1>
<st>
Glaucoma</st>

<p>

A 2007 study published in the <it>European Journal of Ophthalmology</it> found that, along with other treatments for <link xlink:type="simple" xlink:href="../748/74748.xml">
glaucoma</link>, adding alpha-tocopherol appeared to help protect the <link xlink:type="simple" xlink:href="../334/48334.xml">
retina</link> from glaucomatous damage. Groups receiving 300 mg and 600 mg per day of alpha-tocopherol, delivered orally, showed statistically significant decreases in the resistivity index in the posterior ciliary arteries and in the pulsatility index in the ophthalmic arteries, after six and twelve months of therapy. Alpha-tocopherol-treated patients also had significantly lower differences in mean visual field deviations."<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2250%22])">50</ref></p>

</ss1>
<ss1>
<st>
Alzheimer's disease</st>

<p>

<link xlink:type="simple" xlink:href="../017/18914017.xml">
Alzheimer's disease</link> is a wasting disease of the brain. As <link xlink:type="simple" xlink:href="../549/2150549.xml">
oxidative stress</link> may be involved in the <link xlink:type="simple" xlink:href="../246/524246.xml">
pathogenesis</link> of Alzheimer's, tocopherols have been tested as both a means of preventing and treating this disease. The results of these studies have been mixed, with some research suggesting that high levels of vitamin E in the diet may reduce the risk of Alzheimer's, while other studies found no such link.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2251%22])">51</ref> Similarly, studies on if tocopherols could slow the progression of Alzheimer's have also been contradictory, with the Alzheimer’s Disease Cooperative Study suggesting that vitamin E supplementation might be beneficial, but a later trial finding no clinical benefit.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2252%22])">52</ref> Due to this contradictory and confusing evidence, vitamin E or tocopherol supplements are not currently recommended for treating or preventing Alzheimer's disease.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2253%22])">53</ref></p>

</ss1>
<ss1>
<st>
Parkinson's disease</st>
<p>

In May 2005, <it><periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../899/463899.xml">
The Lancet</link></periodical>
 Neurology</it> published a study suggesting that vitamin E may help protect against <link xlink:type="simple" xlink:href="../185/6302185.xml">
Parkinson's disease</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2254%22])">54</ref> Individuals with moderate to high intakes of dietary vitamin E were found to have a lower risk of Parkinson's. No conclusion could be made from this trial about whether supplemental vitamin E has the same effect, however.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2255%22])">55</ref> Other trials have tested if giving vitamin E supplements reduce the risk of Parkinson's disease, or if they can slow the progression of the disease. In a 1998 study, vitamin E supplements had no effect on the rate of progression of this disease<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2256%22])">56</ref></p>

</ss1>
</sec>
<sec>
<st>
See also</st>
<p>

<list>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../753/2427753.xml">
Alkylresorcinols</link></entry>
</list>
</p>

</sec>
<sec>
<st>
References</st>

<p>

<reflist>
<entry id="1">
<it>Merck Index</it>, 11th Edition, <b>9931</b>.</entry>
<entry id="2">
Burton, G. W. and Ingold, K. U., "Autoxidation of biological molecules. 1. Antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro", J. Am. Chem. Soc., 1981, 103, 6472 - 6477.</entry>
<entry id="3">
 <cite style="font-style:normal">Rigotti A&#32;(2007).&#32;"Absorption, transport, and tissue delivery of vitamin E". <it>Mol. Aspects Med.</it>&#32;<b>28</b>&#32;(5-6): 423–36. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.mam.2007.01.002">
10.1016/j.mam.2007.01.002</weblink>. PMID 17320165.</cite>&nbsp;</entry>
<entry id="4">
<it><weblink xlink:type="simple" xlink:href="http://www.nal.usda.gov/fnic/foodcomp/Data/SR20/SR20_doc.pdf">
Composition of Foods Raw, Processed, Prepared USDA National Nutrient Database for Standard Reference, Release 20</weblink></it> <link xlink:type="simple" xlink:href="../896/70896.xml">
USDA</link>, Feb. 2008</entry>
<entry id="5">
 <cite style="font-style:normal">Evans H. M., Bishop K. S.&#32;(1922).&#32;"<weblink xlink:type="simple" xlink:href="http://links.jstor.org/sici?sici=0036-8075%2819221208%293%3A56%3A1458%3C650%3AOTEOAH%3E2.0.CO%3B2-Q">
On the existence of a hitherto unrecognized dietary factor essential for reproduction</weblink>". <it>Science</it>&#32;<b>56</b>&#32;(1458): 650–651. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1126%2Fscience.56.1458.650">
10.1126/science.56.1458.650</weblink>.</cite>&nbsp;</entry>
<entry id="6">
 <cite style="font-style:normal">Evans H. M., Emerson O. H., Emerson G. A.&#32;(1936).&#32;"<weblink xlink:type="simple" xlink:href="http://www.jbc.org/cgi/reprint/113/1/319">
The isolation from wheat germ oil of an alcohol, a-tocopherol, having the properties of vitamin E</weblink>". <it>Journal of Biological Chemistry</it>&#32;<b>113</b>&#32;(1): 319–332.</cite>&nbsp;</entry>
<entry id="7">
 <cite style="font-style:normal">Fernholz E.&#32;(1938).&#32;"On the Constitution of α-Tocopherol". <it><periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../915/1754915.xml">
Journal of the American Chemical Society</link></periodical>
</it>&#32;<b>60</b>&#32;(1): 700–705. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1021%2Fja01270a057">
10.1021/ja01270a057</weblink>.</cite>&nbsp;</entry>
<entry id="8">
 <cite style="font-style:normal">L. Iuliano; F. Micheletta; M. Maranghi; G. Frati; U. Diczfalusy; F. Violi&#32;(2001).&#32;"<weblink xlink:type="simple" xlink:href="http://atvb.ahajournals.org/cgi/content/full/atvbaha;21/10/e34">
Bioavailability of Vitamin E as Function of Food Intake in Healthy Subjects</weblink>". <it>Arteriosclerosis, Thrombosis, and Vascular Biology</it>&#32;<b>21</b>: e34&ndash;e37. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1161%2Fhq1001.098465">
10.1161/hq1001.098465</weblink>. PMID 11597949.</cite>&nbsp;</entry>
<entry id="9">
<weblink xlink:type="simple" xlink:href="http://dietary-supplements.info.nih.gov/factsheets/vitamine.asp">
Vitamin E Fact sheet</weblink></entry>
<entry id="10">
J. Bauernfeind in: L. J. Machlin (ed.): <it>Vitamin E – A Comprehensive Treatise</it>, Marcel Dekker, New York 1980, p. 99</entry>
<entry id="11">
 <cite style="font-style:normal">Brigelius-Flohé R, Traber MG&#32;(July 1999).&#32;"<weblink xlink:type="simple" xlink:href="http://www.fasebj.org/cgi/pmidlookup?view=long&amp;pmid=10385606">
Vitamin E: function and metabolism</weblink>". <it>FASEB J.</it>&#32;<b>13</b>&#32;(10): 1145–55. PMID 10385606.</cite>&nbsp;</entry>
<entry id="12">
 <cite style="font-style:normal">Traber MG, Sies H&#32;(1996).&#32;"Vitamin E in humans: demand and delivery". <it>Annu. Rev. Nutr.</it>&#32;<b>16</b>: 321–47. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1146%2Fannurev.nu.16.070196.001541">
10.1146/annurev.nu.16.070196.001541</weblink>. PMID 8839930.</cite>&nbsp;</entry>
<entry id="13">
 <cite style="font-style:normal">Muller DP, Lloyd JK, Wolff OH&#32;(1983).&#32;"Vitamin E and neurological function: abetalipoproteinaemia and other disorders of fat absorption". <it>Ciba Found. Symp.</it>&#32;<b>101</b>: 106–21. PMID 6557902.</cite>&nbsp;</entry>
<entry id="14">
 <cite style="font-style:normal">Manor D, Morley S&#32;(2007).&#32;"The alpha-tocopherol transfer protein". <it>Vitam. Horm.</it>&#32;<b>76</b>: 45–65. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0083-6729%2807%2976003-X">
10.1016/S0083-6729(07)76003-X</weblink>. PMID 17628171.</cite>&nbsp;</entry>
<entry id="15">
 <cite style="font-style:normal">Weiser H, Riss G, Kormann AW&#32;(October 1996).&#32;"<weblink xlink:type="simple" xlink:href="http://jn.nutrition.org/cgi/pmidlookup?view=long&amp;pmid=8857515">
Biodiscrimination of the eight alpha-tocopherol stereoisomers results in preferential accumulation of the four 2R forms in tissues and plasma of rats</weblink>". <it>J. Nutr.</it>&#32;<b>126</b>&#32;(10): 2539–49. PMID 8857515.</cite>&nbsp;</entry>
<entry id="17">
"Taken together, these data indicate that of the eight stereoisomers (RRR, RSR, RRS, RSS, SRR, SSR, SRS, SSS) in all-rac-α-tocopherol, only the four 2R-forms (RRR, RSR, RSS, RRS) are recognized by α-TTP and maintained in the plasma. Indeed, the Food and Nutrition Board (Food and Nutrition Board and Institute of Medicine, 2000) has defined that only α-tocopherol, specifically the 2R-forms of α-tocopherol, can fulfill the human requirement for vitamin E. Thus, all-rac-α-tocopherol has only half the activity of RRR-α-tocopherol." Taken from the discussion in <weblink xlink:type="simple" xlink:href="http://jas.fass.org/cgi/reprint/80/3/702.pdf">
http://jas.fass.org/cgi/reprint/80/3/702.pdf</weblink>: Relative bioactivity of dietary RRR- and all-rac-alpha-tocopheryl acetates in swine assessed with deuterium-labeled vitamin E1. J Anim Sci  80:702-707, 2002.</entry>
<entry id="16">
 <cite style="font-style:normal">Jensen SK, Lauridsen C&#32;(2007).&#32;"Alpha-tocopherol stereoisomers". <it>Vitam. Horm.</it>&#32;<b>76</b>: 281–308. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0083-6729%2807%2976010-7">
10.1016/S0083-6729(07)76010-7</weblink>. PMID 17628178.</cite>&nbsp;</entry>
<entry id="19">
 <cite style="font-style:normal">Ajandouz el H, Castan S, Jakob S, Puigserver A&#32;(2006).&#32;"A fast, sensitive HPLC method for the determination of esterase activity on alpha-tocopheryl acetate". <it>J Chromatogr Sci</it>&#32;<b>44</b>&#32;(10): 631–3. PMID 17254374.</cite>&nbsp;</entry>
<entry id="18">
 <cite style="font-style:normal">Mathias PM, Harries JT, Peters TJ, Muller DP&#32;(July 1981).&#32;"Studies on the in vivo absorption of micellar solutions of tocopherol and tocopheryl acetate in the rat: demonstration and partial characterization of a mucosal esterase localized to the endoplasmic reticulum of the enterocyte". <it>J. Lipid Res.</it>&#32;<b>22</b>&#32;(5): 829–37. PMID 7288289.</cite>&nbsp;</entry>
<entry id="21">
 <cite style="font-style:normal">Cheeseman KH, Holley AE, Kelly FJ, Wasil M, Hughes L, Burton G&#32;(November 1995).&#32;"Biokinetics in humans of RRR-alpha-tocopherol: the free phenol, acetate ester, and succinate ester forms of vitamin E". <it>Free Radic. Biol. Med.</it>&#32;<b>19</b>&#32;(5): 591–8. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0891-5849%2895%2900083-A">
10.1016/0891-5849(95)00083-A</weblink>. PMID 8529918.</cite>&nbsp;</entry>
<entry id="20">
 <cite style="font-style:normal">Horwitt M, Elliott W, Kanjananggulpan P, Fitch C&#32;(1984).&#32;"Serum concentrations of alpha-tocopherol after ingestion of various vitamin E preparations". <it>Am J Clin Nutr</it>&#32;<b>40</b>&#32;(2): 240–5. PMID 6465056.</cite>&nbsp; <weblink xlink:type="simple" xlink:href="http://www.ajcn.org/cgi/reprint/40/2/240.pdf">
link</weblink></entry>
<entry id="23">
 <cite style="font-style:normal">Mathias PM, Harries JT, Muller DP&#32;(January 1981).&#32;"<weblink xlink:type="simple" xlink:href="http://www.jlr.org/cgi/pmidlookup?view=long&amp;pmid=7217783">
Optimization and validation of assays to estimate pancreatic esterase activity using well-characterized micellar solutions of cholesteryl oleate and tocopheryl acetate</weblink>". <it>J. Lipid Res.</it>&#32;<b>22</b>&#32;(1): 177–84. PMID 7217783.</cite>&nbsp;</entry>
<entry id="22">
 <cite style="font-style:normal">Burton GW, Ingold KU, Foster DO, et al&#32;(September 1988).&#32;"Comparison of free alpha-tocopherol and alpha-tocopheryl acetate as sources of vitamin E in rats and humans". <it>Lipids</it>&#32;<b>23</b>&#32;(9): 834–40. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1007%2FBF02536201">
10.1007/BF02536201</weblink>. PMID 3185118.</cite>&nbsp;</entry>
<entry id="25">
M. Houston, <weblink xlink:type="simple" xlink:href="http://www.antiaging.com/white_papers/vitamin_e_jana.html">
“Meta-Analysis, Metaphysics and Mythology”</weblink> <it>JANA</it> Vol. 8 No. 1, 2005  <weblink xlink:type="simple" xlink:href="http://ana-jana.org/reprints/VitaminEEditorialbyMarkHouston,_MD.pdf">
original</weblink></entry>
<entry id="24">
Bailey H  (1964) <it>Vitamin E: Your Key to a Healthy Heart</it>, Chilton Books, ASIN B000GS9VPQ  <it>Bailey describes mixed tocopherols use for CVD back to the 1940s</it>Walker M, <weblink xlink:type="simple" xlink:href="http://www.enerex.ca/articles/new_old_findings_on_unique_vitamin_e.htm">
"New/Old Findings on Unique Vitamin E"</weblink>, Townsend Letter for Doctors and Patients, No. 111, 1992, p. 826 that the other poorly studied tocopherols, especially the abundant d-gamma-tocopherol,MacWilliam L,<weblink xlink:type="simple" xlink:href="http://www.lef.org/magazine/mag2006/apr2006_report_gamma_01.htm">
"What Makes Gamma Tocopherol Superior to Alpha Tocopherol"</weblink>, <it>LE</it> Magazine, Report, April 2006</entry>
<entry id="27">
 <cite style="font-style:normal">Miller E, Pastor-Barriuso R, Dalal D, Riemersma R, Appel L, Guallar E&#32;(2005).&#32;"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.". <it>Ann Intern Med</it>&#32;<b>142</b>&#32;(1): 37–46. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:10.1016/j.freeradbiomed.2007.06.019. (inactive <link>
2008-06-25</link>) . PMID 15537682.</cite>&nbsp;</entry>
<entry id="26">
Carter, T. <weblink xlink:type="simple" xlink:href="http://www.annals.org/cgi/reprint/143/2/155-a.pdf">
"Responses and Comments: High-Dosage Vitamin E Supplementation and All-Cause Mortality"</weblink>, <it>Ann Intern Med</it>. 2005 July 19;143(2):155; responses 150-160</entry>
<entry id="29">
<weblink xlink:type="simple" xlink:href="http://www.dermweb.com/skintherapy/stl0103.html">
Topical Vitamin E Formulations: Not Always Benign</weblink>, <it>Skin Therapy Letter</it> Vol. 1, No. 3, January 1996</entry>
<entry id="28">
Bjelakovic et al., "Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis", <it>JAMA</it>, 297:842; <link xlink:type="simple" xlink:href="../311/11311.xml">
February 28</link>, <link xlink:type="simple" xlink:href="../165/36165.xml">
2007</link> <weblink xlink:type="simple" xlink:href="http://jama.ama-assn.org/cgi/content/abstract/297/8/842">
http://jama.ama-assn.org/cgi/content/abstract/297/8/842</weblink></entry>
<entry id="31">
 <cite style="font-style:normal">O'Brien L, Pandit A&#32;(2006).&#32;"Silicon gel sheeting for preventing and treating hypertrophic and keloid scars". <it>Cochrane Database Syst Rev</it>&#32;(1): CD003826. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2F14651858.CD003826.pub2">
10.1002/14651858.CD003826.pub2</weblink>. PMID 16437463.</cite>&nbsp;</entry>
<entry id="30">
 <cite style="font-style:normal">Palmieri B, Gozzi G, Palmieri G&#32;(1995).&#32;"Vitamin E added silicone gel sheets for treatment of hypertrophic scars and keloids". <it>Int. J. Dermatol.</it>&#32;<b>34</b>&#32;(7): 506–9. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1111%2Fj.1365-4362.1995.tb00628.x">
10.1111/j.1365-4362.1995.tb00628.x</weblink>. PMID 7591421.</cite>&nbsp;</entry>
<entry id="34">
 <cite style="font-style:normal">Poston L, Briley A, Seed P, Kelly F, Shennan A&#32;(2006).&#32;"Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.". <it>Lancet</it>&#32;<b>367</b>&#32;(9517): 1145–54. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0140-6736%2806%2968433-X">
10.1016/S0140-6736(06)68433-X</weblink>. PMID 16616557.</cite>&nbsp;</entry>
<entry id="35">
 <cite style="font-style:normal">Vivekananthan D, Penn M, Sapp S, Hsu A, Topol E&#32;(2003).&#32;"Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.". <it>Lancet</it>&#32;<b>361</b>&#32;(9374): 2017–23. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0140-6736%2803%2913637-9">
10.1016/S0140-6736(03)13637-9</weblink>. PMID 12814711.</cite>&nbsp;</entry>
<entry id="32">
 <cite style="font-style:normal">Baumann LS, Spencer J&#32;(1999).&#32;"The effects of topical vitamin E on the cosmetic appearance of scars". <it>Dermatol Surg</it>&#32;<b>25</b>&#32;(4): 311–5. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1046%2Fj.1524-4725.1999.08223.x">
10.1046/j.1524-4725.1999.08223.x</weblink>. PMID 10417589. <weblink xlink:type="simple" xlink:href="http://www.cosmeticscop.com/learn/art.asp?ID=385">
Lay summary</weblink>&nbsp;&ndash;&nbsp;<it>Vitamin E - Paula Begoun at CosmeticsCop</it>&#32;(<link>
2008-01-01</link>).</cite>&nbsp;</entry>
<entry id="33">
 <cite style="font-style:normal">Rumbold A, Crowther C, Haslam R, Dekker G, Robinson J&#32;(2006).&#32;"Vitamins C and E and the risks of pre-eclampsia and perinatal complications.". <it>N Engl J Med</it>&#32;<b>354</b>&#32;(17): 1796–806. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJMoa054186">
10.1056/NEJMoa054186</weblink>. PMID 16641396.</cite>&nbsp;</entry>
<entry id="38">
<weblink xlink:type="simple" xlink:href="http://news.yahoo.com/s/nm/20070910/hl_nm/heart_vitamin_dc;_ylt=AkMyAMESSKMB5tgbScXyko.s0NUE">
Yahoo.com, Vitamin E may reduce blood clots in women: study</weblink></entry>
<entry id="39">
  <cite style="font-style:normal">Helzlsouer K, Huang H, Alberg A, Hoffman S, Burke A, Norkus E, Morris J, Comstock G&#32;(2000).&#32;"Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer". <it>J Natl Cancer Inst</it>&#32;<b>92</b>&#32;(24): 2018–23. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1093%2Fjnci%2F92.24.2018">
10.1093/jnci/92.24.2018</weblink>. PMID 11121464.</cite>&nbsp;</entry>
<entry id="36">
 <cite style="font-style:normal">Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold J, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais G&#32;(2005).&#32;"Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.". <it>JAMA</it>&#32;<b>293</b>&#32;(11): 1338–47. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Fjama.293.11.1338">
10.1001/jama.293.11.1338</weblink>. PMID 15769967.</cite>&nbsp;</entry>
<entry id="37">
 <cite style="font-style:normal">Huang HY, Appel LJ&#32;(2003).&#32;"Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans". <it>J. Nutr.</it>&#32;<b>133</b>&#32;(10): 3137–40. PMID 14519797.</cite>&nbsp;</entry>
<entry id="42">
<weblink xlink:type="simple" xlink:href="http://www.nursinginpractice.com/default.asp?title=VitaminE%22linkedtocancer%22&amp;page=article.display&amp;article.id=8926">
Nursing in Practice - Vitamin E "linked to cancer"</weblink></entry>
<entry id="43">
<weblink xlink:type="simple" xlink:href="http://www.ecanadanow.com/news/health/vitamin-e-linked-to-increased-risk-of-lung-cancer-20080303.html">
eCanadaNow.com - Vitamin E Linked To Increased Risk of Lung Cancer</weblink></entry>
<entry id="40">
 <cite style="font-style:normal">Beta Carotene Cancer Prevention Study Group The Alpha-Tocopherol,&#32;(1994).&#32;"The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group". <it>N Engl J Med</it>&#32;<b>330</b>&#32;(15): 1029–35. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJM199404143301501">
10.1056/NEJM199404143301501</weblink>. PMID 8127329.</cite>&nbsp;</entry>
<entry id="41">
<weblink xlink:type="simple" xlink:href="http://info.cancerresearchuk.org/news/archive/newsarchive/2008/march/18493364">
Cancer Research UK : Jury still out over vitamin E supplements and increased lung cancer risk</weblink></entry>
<entry id="46">
  <cite style="font-style:normal">Taylor H, Tikellis G, Robman L, McCarty C, McNeil J&#32;(2002).&#32;"Vitamin E supplementation and macular degeneration: randomised controlled trial". <it>BMJ</it>&#32;<b>325</b>&#32;(7354): 11. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1136%2Fbmj.325.7354.11">
10.1136/bmj.325.7354.11</weblink>. PMID 12098721.</cite>&nbsp;</entry>
<entry id="47">
 <cite style="font-style:normal">&#32;"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8"&#32;&#32;(2001). <it>Arch Ophthalmol</it>&#32;<b>119</b>&#32;(10): 1417–36. PMID 11594942.</cite>&nbsp;</entry>
<entry id="44">
 <cite style="font-style:normal">&#32;"<weblink xlink:type="simple" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=11594943">
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9</weblink>"&#32;&#32;(October 2001). <it>Arch. Ophthalmol.</it>&#32;<b>119</b>&#32;(10): 1439–52. PMID 11594943.</cite>&nbsp;</entry>
<entry id="45">
 <cite style="font-style:normal">McNeil JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor HR&#32;(January 2004).&#32;"Vitamin E supplementation and cataract: randomized controlled trial". <it>Ophthalmology</it>&#32;<b>111</b>&#32;(1): 75–84. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.ophtha.2003.04.009">
10.1016/j.ophtha.2003.04.009</weblink>. PMID 14711717.</cite>&nbsp;</entry>
<entry id="51">
 <cite style="font-style:normal">Frank B, Gupta S&#32;(2005).&#32;"A review of antioxidants and Alzheimer's disease". <it>Ann Clin Psychiatry</it>&#32;<b>17</b>&#32;(4): 269–86. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1080%2F10401230500296428">
10.1080/10401230500296428</weblink>. PMID 16402761.</cite>&nbsp;</entry>
<entry id="50">
 <cite style="font-style:normal">Engin KN, Engin G, Kucuksahin H, Oncu M, Engin G, Guvener B&#32;(2007).&#32;"Clinical evaluation of the neuroprotective effect of alpha-tocopherol against glaucomatous damage". <it>European journal of ophthalmology</it>&#32;<b>17</b>&#32;(4): 528–33. PMID 17671926.</cite>&nbsp;</entry>
<entry id="49">
 <cite style="font-style:normal">Moriarty-Craige S, Adkison J, Lynn M, Gensler G, Bressler S, Jones D, Sternberg P&#32;(2005).&#32;"Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration". <it>Am J Ophthalmol</it>&#32;<b>140</b>&#32;(6): 1020–6. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.ajo.2005.06.043">
10.1016/j.ajo.2005.06.043</weblink>. PMID 16376645.</cite>&nbsp;</entry>
<entry id="48">
 <cite style="font-style:normal">van Leeuwen R, Boekhoorn S, Vingerling J, Witteman J, Klaver C, Hofman A, de Jong P&#32;(2005).&#32;"Dietary intake of antioxidants and risk of age-related macular degeneration". <it>JAMA</it>&#32;<b>294</b>&#32;(24): 3101–7. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Fjama.294.24.3101">
10.1001/jama.294.24.3101</weblink>. PMID 16380590.</cite>&nbsp;</entry>
<entry id="55">
"<weblink xlink:type="simple" xlink:href="http://news.bbc.co.uk/2/hi/health/4559051.stm">
Vitamin E cuts Parkinson's risk</weblink>", BBC News&#32;(19 May, 2005).&#32;Retrieved on <link>
2008-01-01</link>.&nbsp;</entry>
<entry id="54">
 <cite style="font-style:normal">Etminan M, Gill SS, Samii A&#32;(2005).&#32;"Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis". <it>Lancet Neurol</it>&#32;<b>4</b>&#32;(6): 362–5. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS1474-4422%2805%2970097-1">
10.1016/S1474-4422(05)70097-1</weblink>. PMID 15907740.</cite>&nbsp;</entry>
<entry id="53">
 <cite style="font-style:normal">Boothby LA, Doering PL&#32;(December 2005).&#32;"Vitamin C and vitamin E for Alzheimer's disease". <it>Ann Pharmacother</it>&#32;<b>39</b>&#32;(12): 2073–80. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1345%2Faph.1E495">
10.1345/aph.1E495</weblink>. PMID 16227450.</cite>&nbsp;</entry>
<entry id="52">
 <cite style="font-style:normal">Ricciarelli R, Argellati F, Pronzato MA, Domenicotti C&#32;(2007).&#32;"Vitamin E and neurodegenerative diseases". <it>Mol. Aspects Med.</it>&#32;<b>28</b>&#32;(5-6): 591–606. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.mam.2007.01.004">
10.1016/j.mam.2007.01.004</weblink>. PMID 17306357.</cite>&nbsp;</entry>
<entry id="56">
 <cite style="font-style:normal">Shoulson I&#32;(September 1998).&#32;"DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism". <it>Ann. Neurol.</it>&#32;<b>44</b>&#32;(3 Suppl 1): S160–6. PMID 9749589.</cite>&nbsp;</entry>
</reflist>
</p>

</sec>
<sec>
<st>
External links</st>
<p>

<list>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://whyweage.com/node/15">
Vitamin E - Its Role and Mechanism of Action</weblink></entry>
<entry level="1" type="bullet">

 Jane Higdon, "<weblink xlink:type="simple" xlink:href="http://lpi.oregonstate.edu/infocenter/vitamins/vitaminE/">
Vitamin E</weblink>", Micronutrient Information Center, <it><university wordnetid="108286163" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../155/233155.xml">
Linus Pauling Institute</link></university>
''</it></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://ods.od.nih.gov/factsheets/vitamine.asp">
US Office of Dietary Supplements article on Vitamin E</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.benbest.com/nutrceut/VitaminE.html">
Vitamin E (Tocopherols and Tocotrienols)</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.food.gov.uk/multimedia/pdfs/evm_e.pdf">
Vitamin E risk assessment</weblink>, Expert Group on Vitamins and Minerals, UK <division wordnetid="108220714" confidence="0.8">
<administrative_unit wordnetid="108077292" confidence="0.8">
<department wordnetid="108114861" confidence="0.8">
<link xlink:type="simple" xlink:href="../848/429848.xml">
Food Standards Agency</link></department>
</administrative_unit>
</division>
, 2003</entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.newscientist.com/article.ns?id=dn7942">
High dose vitamin E leads to longer more active lives in mice</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://ethesis.helsinki.fi/julkaisut/laa/kansa/vk/hemila/">
Do vitamins C and E affect respiratory infections? (Dissertation 2006)</weblink></entry>
</list>
</p>

<p>

<table style=";" class="navbox" cellspacing="0">
<row>
<col style="padding:2px;">
<table style="width:100%;background:transparent;color:inherit;;" class="nowraplinks collapsible autocollapse " cellspacing="0">
<row>
<header colspan="2" style=";" class="navbox-title">
<link xlink:type="simple" xlink:href="../512/32512.xml">
Vitamin</link>s (<written_communication wordnetid="106349220" confidence="0.8">
<code wordnetid="106667317" confidence="0.8">
<link xlink:type="simple" xlink:href="../077/817077.xml">
A11</link></code>
</written_communication>
)</header>
</row>
<row style="height:2px;">

</row>
<row>
<col style=";background:#fd6;;" class="navbox-group">
Fat soluble</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<b><link xlink:type="simple" xlink:href="../114/54114.xml">
A</link>:</b> <link xlink:type="simple" xlink:href="../115/54115.xml">
Retinol</link> - <link xlink:type="simple" xlink:href="../219/579219.xml">
Beta-carotene</link> - <link xlink:type="simple" xlink:href="../902/637902.xml">
Tretinoin</link> - <link xlink:type="simple" xlink:href="../972/580972.xml">
Alpha-carotene</link><p>

<b><link xlink:type="simple" xlink:href="../106/54106.xml">
D3</link>:</b> <link xlink:type="simple" xlink:href="../533/52533.xml">
7-Dehydrocholesterol</link> → <link xlink:type="simple" xlink:href="../397/9695397.xml">
Previtamin D3</link> → <link xlink:type="simple" xlink:href="../084/470084.xml">
Cholecalciferol (D3)</link> → <link xlink:type="simple" xlink:href="../355/6832355.xml">
Calcidiol</link> → <link xlink:type="simple" xlink:href="../872/2200872.xml">
Calcitriol (active form)</link> → <link xlink:type="simple" xlink:href="../977/11895977.xml">
Calcitroic acid</link></p>
<p>

D2: <link xlink:type="simple" xlink:href="../910/842910.xml">
Ergosterol</link> → <link xlink:type="simple" xlink:href="../087/470087.xml">
Ergocalciferol (D2)</link></p>
<p>

D analogues: <link xlink:type="simple" xlink:href="../559/2677559.xml">
Dihydrotachysterol</link> - <preparation wordnetid="101143040" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<link xlink:type="simple" xlink:href="../761/2623761.xml">
Calcipotriol</link></activity>
</psychological_feature>
</act>
</event>
</preparation>
 - <link xlink:type="simple" xlink:href="../548/13024548.xml">
Tacalcitol</link></p>
<p>

D4: <link xlink:type="simple" xlink:href="../750/19220750.xml">
Dihydroergocalciferol</link></p>
<p>

<b>E:</b> <link xlink:type="simple" xlink:href="../105/54105.xml">
Tocopherol</link> - <link xlink:type="simple" xlink:href="../306/2891306.xml">
Tocotrienol</link></p>
<p>

<b>K:</b> <link xlink:type="simple" xlink:href="../541/32541.xml">
Naphthoquinone</link> - <link xlink:type="simple" xlink:href="../091/3115091.xml">
Phylloquinone/K1</link> - <compound wordnetid="105870180" confidence="0.8">
<link xlink:type="simple" xlink:href="../865/9695865.xml">
Menatetrenone/K2</link></compound>
</p>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#fd6;;" class="navbox-group">
Water soluble: <link xlink:type="simple" xlink:href="../926/457926.xml">
<b>B vitamins</b></link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<b>B1</b> (<link xlink:type="simple" xlink:href="../500/30500.xml">
Thiamine</link>) - <b>B2</b> (<link xlink:type="simple" xlink:href="../229/26229.xml">
Riboflavin</link>) - <b>B3</b> (<link xlink:type="simple" xlink:href="../996/37996.xml">
Niacin</link>, <link xlink:type="simple" xlink:href="../968/21968.xml">
Nicotinamide</link>) - <b>B5</b> (<link xlink:type="simple" xlink:href="../099/54099.xml">
Pantothenic acid</link>, <substance wordnetid="100020090" confidence="0.8">
<substance wordnetid="100019613" confidence="0.8">
<food wordnetid="100021265" confidence="0.8">
<chemical wordnetid="114806838" confidence="0.8">
<nutriment wordnetid="107570720" confidence="0.8">
<vitamin wordnetid="115089258" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<material wordnetid="114580897" confidence="0.8">
<link xlink:type="simple" xlink:href="../200/2943200.xml">
Dexpanthenol</link></material>
</part>
</vitamin>
</nutriment>
</chemical>
</food>
</substance>
</substance>
, <link xlink:type="simple" xlink:href="../415/5703415.xml">
Pantethine</link>) -  <b><link xlink:type="simple" xlink:href="../110/54110.xml">
B6</link></b> (<link xlink:type="simple" xlink:href="../637/1205637.xml">
Pyridoxine</link>, <link xlink:type="simple" xlink:href="../176/905176.xml">
Pyridoxal phosphate</link>, <link xlink:type="simple" xlink:href="../858/564858.xml">
Pyridoxamine</link>) - <b>B7</b> (<link xlink:type="simple" xlink:href="../118/54118.xml">
Biotin</link>) - <b>B9</b> (<link xlink:type="simple" xlink:href="../117/54117.xml">
Folic acid</link>, <adjuvant wordnetid="102680947" confidence="0.8">
<component wordnetid="103081021" confidence="0.8">
<part wordnetid="103892891" confidence="0.8">
<addition wordnetid="102679415" confidence="0.8">
<additive wordnetid="102679788" confidence="0.8">
<link xlink:type="simple" xlink:href="../842/995842.xml">
Folinic acid</link></additive>
</addition>
</part>
</component>
</adjuvant>
) - <b><link xlink:type="simple" xlink:href="../619/14538619.xml">
B12</link></b> (<link xlink:type="simple" xlink:href="../634/14538634.xml">
Cyanocobalamin</link>, <compound wordnetid="105870180" confidence="0.8">
<link xlink:type="simple" xlink:href="../428/8823428.xml">
Hydroxocobalamin</link></compound>
, <compound wordnetid="105870180" confidence="0.8">
<link xlink:type="simple" xlink:href="../725/5124725.xml">
Methylcobalamin</link></compound>
, <compound wordnetid="105870180" confidence="0.8">
<link xlink:type="simple" xlink:href="../009/10969009.xml">
Cobamamide</link></compound>
)</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#fd6;;" class="navbox-group">
Water soluble: other</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<b><link xlink:type="simple" xlink:href="../509/32509.xml">
C</link></b> (<link xlink:type="simple" xlink:href="../ury/23rd_century.xml">
Ascorbic acid</link>) - <link xlink:type="simple" xlink:href="../799/158799.xml">
Choline</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<it>see also ''</it></col>
</row>
</table>
</col>
</row>
</table>
</p>



</sec>
</bdy>
</antioxidant>
</chemical>
</article>
